斜纹夜蛾多角体病毒包埋型病毒受体的鉴定

蔗糖密度梯度离心法提纯斜纹夜蛾核多角体病毒（＄Ｓｐｏｄｏｐｔｅｒａ　ｌｉｔｕｒａ　　ｍｕｌｔｉｎｕｃｌｅｏｃａｐｓｉｄ　ｎｕｃｌｅｏｐｏｌｙｈｄｒｏｖｉｒｕｓ,　ＳｐｌｔＭＮＰＶ）包埋型病毒粒子（ｐｏｌｙｈｅｄｒａ－ｄｅｒｉｖｅｄ　ｖｉｒｕｓ,ＰＤＶ）,以此病毒粒子作抗原,免疫家兔获得抗血清;用ＳＤＳ裂解缓冲液提取斜纹夜蛾幼虫中肠组织细胞总蛋白。采用病毒铺覆蛋白印迹技术（ＶＯＰＢＡ）,利用抗ＰＶＤ抗血清对病毒受体进行检测,结果表明斜纹夜蛾中肠细胞总蛋白中４０ｋＤ、７３ｋＤ、８５ｋＤ的三种蛋白能够结合ＰＤＶ。     

检测肾综合征出血热抗原特异性循环免疫复合物ELISA方法的建立

检测肾综合征出血热抗原特异性循环免疫复合物ＥＬＩＳＡ方法的建立张东海,孙辉,高峰（山东省淄博第二卫生学校,淄博２５５０１５）关键词肾综合征出血热病毒,循坏免疫复合物,特异性,ＥＬＩＳＡ肾综合征出血热（ＨＦＲＳ）发病机理有多种学说,其中在体液免疫学说中...     

从云南烟草上检测到的黄瓜花叶病毒亚组Ⅱ分离物*

在对云南省烟草病毒病的研究中,分离到一种直径约２６￣３０ｎｍ的球形病毒。提纯病毒进行的ＳＤＳ－ＰＡＧＥ发现一条５５ｋＤ蛋白带。５５ｋＤ蛋白Ｎ－端１０个氨基酸与ＣＭＶ亚组Ⅱ的Ｑ株系外壳蛋白Ｎ－氨基酸同源性为１００％。以ＣＭＶ－Ｑ抗血清对５５ｋＤ蛋白进行了Ｗｅｓｔｅｒｎ ｂｌｏｔ检测,发现５５ｋＤ蛋白与ＣＭＶ Ｑ株系抗血清有血清学反应。根据已报道的ＣＭＶ亚组Ⅱ外壳蛋白基因序列合成引物,采用ＲＴ－ＰＣＲ     

应用亲和层析法是纯鸡马立克氏病病毒PP38基因重组产物

利用鸡马立氏病病毒（ＭＤＶ）Ｉ型特异单克隆抗体Ｈ１９致敏Ｓｅｐｈａｒｏｓｅ４Ｂ－ＣＮＢｒ,从感染重组病毒ＢＰ３８Ⅱ的昆虫细胞中提纯鸡马立克氏病毒ＰＰ３８基因重组产物,获得良好效果,提纯的蛋白质的ＳＤＳ－ＰＡＧＥ中表现出一条分子量约为３８ｋＤａ的蛋白质条带,在免疫印迹试验中该蛋白质带也能被单克隆抗体Ｈ１９识别。利用该提纯的重组ＰＰ３８免疫小鼠,所制备的小鼠抗血清在免疫荧光染色试验中不仅能与感染重组病     

流行性出血热患者皮肤组织内病毒抗原及免疫复合物检测与意义

应用常规病理、免疫病理及超微病理技术,对３３例流行性出血热（ＥＨＦ）患者皮肤活检标本的病理变化及病毒抗原、免疫复合物进行观察,同时与血清病毒抗原、抗体及循环免疫复合物检出情况进行比较。在２３例ＥＨＦ患者皮肤微血管内皮细胞中检出病毒抗原,部分组织中可同时检出免疫球蛋白及Ｃ３,少数组织仅能检出病毒抗原或免疫球蛋白。配对血清小也可检出ＥＨＦ病毒抗原、抗体及循环免疫复合物。组织及血清免疫复合物形成与血清补体Ｃ３水平下降有关,组织内肥大细胞脱颗粒与血清ＩｇＥ水平升高相关,提示多种变态反应参与了流行性出血热的发病机制。     

马铃薯Y病毒普通系外壳蛋白基因在大肠杆菌中的表达

将马铃薯Ｙ病毒普通系（ＰＶＹ０）的外壳蛋白基因克隆到表达质粒ｐＭＡＬｃ２中,构建这一基因在大肠杆菌中的表达载体ｐＭＡＬｃ２ＰＶＹ０ＣＰ。ＳＤＳＰＡＧＥ及Ｗｅｓｔｅｒｎｂｌｏｔｉｎｇ检测结果表明,这一表达栽体在Ｅ．ｃｏｌｉＤＨ５α中经ＩＰＴＧ诱导可表达分子量为７１．８ｋＤａ的特异性融合蛋白。以ａｍｙｌｏｓｅｒｅｓｉｎ亲合柱层析纯化这一融合蛋白为抗原,免疫家兔制备了效价为１∶１０２４的特异性抗血清。用该抗血清可通过对流免疫电泳、免疫双扩散及Ｗｅｓｔｅｒｎｂｌｏｔｉｎｇ对ＰＶＹ进行检测     

以痘苗病毒天坛株为载体的表达单纯疱疹病毒Ⅰ型糖蛋白D的重组活疫苗的建立

从我国分离到的一株单纯疱疹病毒Ⅰ型（ＨＳＶ－１－１６８株）病毒基因组中,分离出含有糖蛋白Ｄ（ｇＤ）基因的１．２ｋｂ片段,插入带有痘苗病毒天坛株ＴＫ区的质粒ｐＪＳＢ１１７５Ｐ７．５ｋ启动子下游,转染无白血病鸡胚原代细胞,获得带有ＨＳＶ－１－１６８ｇＤ基因的重组痘苗病毒。此株重组病毒在感染细胞膜上表达ＨＳＶ－１－１６８ｇＤ糖蛋白抗原,能与特异性单克隆抗体反应。在感染细胞中表达的膜抗原经ＳＤＳ－ＰＡＧＥ分析,表达分子量为５４ｋＤ糖蛋白。用Ｓｏｕｔｈｅｒｎ杂交分析了重组病毒ＤＮＡ中特异的ｇＤ基因,对作为活疫苗的重组痘苗病毒株进行了一些微生物学活性、免疫原性和毒力等方面的研究。     

我国单纯疱疹病毒I型168株糖蛋白D基因的克隆及其在痘苗病毒天坛…

将我国单纯疱疹病毒Ｉ型１６８株基因组ＤＮＡ中扩增出的糖蛋白Ｄ基因,插入痘苗病毒ｐ７．５启动子下游,使其在痘苗病毒天坛株表达,免疫荧光分析表明,产生的重组病毒糖蛋白Ｄ能被运到被重且病毒感染的１４３细胞表面表达,表达的产物经Ｗｅｓｔｅｎｂｌｏｔ鉴定为分子量约５０ｋＤ的多肽,Ｓｏｕｔｈｅｒｎｂｌｏｔ证明重组病毒基因组中整合有ＨＳＶ－１１６８株糖蛋白基因片段,重组病毒免疫家兔后,产生了高滴度的ＨＳＶ特异性     

我国单纯疱疹病毒Ⅰ型168株糖蛋白D基因的克隆及其在痘苗病毒天坛株中的表达

将我国单纯疮疹病毒Ⅰ型１６８株基因组ＤＮＡ中扩增出的糖蛋白Ｄ基因,插入痘苗病毒ｐ７．５启动子下游,使其在痘苗病毒天坛株表达。免疫荧光分析表明,产生的重组病毒糖蛋白Ｄ能被运到被重组病毒感染的１４３细胞表面表达,表达的产物经Ｗｅｓｔｅｍｂｌｏｔ鉴定为分子量约５０ｋＤ的多肽。Ｓｏｕｔｈｅｍｂｌｏｔ证明重组病毒基因组中整合有ＨＳＶ－１１６８株糖蛋白基因片段,重组病毒免疫家兔后,产生了高滴度的ＨＳＶ特异性中和抗体。     

大鼠骨骼肌多催化功能蛋白酶的提取、鉴定及其抗血清的制备

为了研究多催化功能蛋白酶（ｍｕｌｔｉｃａｔａｌｙｔｉｃａｌｐｒｏｔｅｉｎａｓｅ,ＭＣＰ）在负氮平衡形成中的作用,以大鼠骨骼肌为原料,提取此酶并制备其抗血清．将大鼠骨骼肌粗提物经４５％～６５％饱和度硫酸铵分级盐析、阴离子交换层析和凝胶过滤,最后从Ｓｅｐｈａｒｏｓｅ４Ｂ层析柱上获得单一活性洗脱峰．酶活性用Ｃａｒｂｏｂｅｎｚｏｘｙ－Ｖａｌ－Ｇｌｙ－Ａｒｇ－４－ｎｉｔｒｉｎｉｌｉｄｅａｃｅｔａｔｅ作底物检测．非变性ＰＡＧＥ银盐染色显示单一区带的骨骼肌多催化功能蛋白酶,ＳＤＳ－ＰＡＧＥ银盐染色显示１０条亚基电泳区带,分子量在２５～３２ｋＤ之间．纯化的酶免疫兔８周后,抗血清效价达１３２,用分级盐析和离子交换层析纯化抗血清,显示单一电泳区带的ＩｇＧ．Ｗｅｓｔｅｒｎ－ｂｌｏｔ分析显示只在２５～３２ｋＤ之间出现多条亚基区带．这些结果提示已获得电泳纯ＭＣＰ及其较高特异性的多克隆抗体．     

Study of circulating immune complexes in three hematologic diseases: Acute myeloid leukemia,acute lymphatic leukemia,and hematosarcoma

Summary Circulating immune complexes (CIC) were detected by means of the polyethylen glycol (PEG) precipitation method, in the serum of untreated patients with hematologic diseases including acute myeloid leukemia (AML), acute lymphatic leukemia (ALL) and hematosarcoma (HS). Immunoglobulins (Ig) and the C ₄ fraction of complement were quantitated in the precipitate dissociated by potassium cyanate (KCNO) and in the serum. When compared to control sera, the results showed a simultaneous increase of both precipitate and Ig component. The proportion of each Ig in the precipitate was stable for the controls but variable for the patients. On the whole precipitated proteins, 30% were systematically quantitated in patients and controls. In the remaining portion were noticed Clq and C ₃ fractions of complement as well as haptoglobin and albumin. The nature of the antigen was discussed.     

乳鼠感染流行性出血热病毒的研究

用获自病人的流行性出血热(EHF)病毒H8205株感染Vero-E6细胞的培养液,感染1日龄小白鼠,自第3代起,感染鼠出现规律发病,潜伏期13～18天,个体瘦小,后肢麻痹,最后死亡。病理检查感染鼠脑有典型病毒性脑炎改变,免疫荧光及酶标抗体染色证实脏器中存在特异性抗原,血内有特异性抗体,感染鼠的血,尿及脏器悬液经Vero-E6细胞培养出病毒。电镜检查脑神经原细胞高尔基氏器内有病毒颗粒。实验结果说明1日龄小白鼠对流行性出血热病毒是敏感的,可以作为该病毒的实验动物模型。     

Circulating immune complexes and complement C3 and C4 levels in a selected group of patients with rhinitis in Lebanon

BACKGROUND: A number of reports indicate that circulating immune complexes (CIC) and activation of the complement system contribute to the pathogenesis of Type I allergy. The aim of this study was to investigate the status of CIC in 113 patients with rhinitis in Lebanon and determine complement components C3 and C4 serum levels in the CIC-positive patients. Serum specific IgE antibodies were previously detected and reported in 74 of the 113 patients. METHODS: CIC were detected by polyethylene glycol precipitation and serum C3 and C4 levels quantified by radial immunodiffusion. RESULTS: CIC was positive in 20 of the specific IgE-positive and 13 of the specific IgE-negative patients. C3 and C4 levels were within the normal range in all the 33 CIC-positive patients. CONCLUSIONS: The antibody class that constitutes the complexes does not seem to be IgG or IgM. Moreover, complement activation does not seem to be involved in the allergic reaction since both C3 and C4 levels were normal in all patients. The role of these complexes, if any, in the pathogenesis of rhinitis is yet to be determined.     

Microprecipitation test for the detection of adenovirus antibody

A microprecipitation test (MPT) for the detection of adenovirus antibody has been developed. The new procedure combines precipitation of virus particles with specific antibody, separation of unreacted components from the resulting electroneutral virus-antibody complexes by electrophoresis, and detection of these complexes with a protein stain. Type-specific antibody was detected in rabbit antisera but, under similar conditions, antibody in convalescent human sera reacted with adnovirus antigens of types 4 and 7. Paired sera from 57 patients with suspected adenovirus infection were examined for significant rises in antibody activity by the microprecipitation test and by complement fixation.     

Spontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virus.

The regressing and conventional strains of Friend virus were compared by neutralization assays, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and tryptic peptide mapping of the individual viral components. Neutralization rates of the two viruses differed in the presence of monospecific anti-gp70 antiserum and sera from regressed or immunized mice. Neutralization of regressing Friend virus, but not conventional Friend virus, occurred when the viruses were incubated with anti-p15(E) and complement. Human serum inactivated conventional Friend virus more rapidly than regressing Friend virus, probably as a result of virolysis induced by the reaction of viral p15(E) with human complement component C1. Structural differences between the viruses were detected in their gp70 viral glycoproteins and p15(E) and p12 proteins. Analysis of different stocks and clonal isolates of the viruses showed that the differences between the gp70 and p15(E), but not the p12 proteins, were associated with the regressing phenotype of the regressing strain of Friend virus.     

Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement

All normal human sera examined neutralized WS/33 H1N1 influenza virus efficiently by one of two antibody-dependent mechanisms. A minority of the sera contained moderate levels of IgG antibody directed against the viral hemagglutinin that had the ability to directly neutralize the virus. The majority of sera tested contained very low levels of IgG anti-hemagglutinin antibody, which was detectable with a specific ELISA but not by conventional HAI assays. Such IgG antibody was unable to directly neutralize the virus. Studies with agammaglobulinemic serum and with sera depleted of and reconstituted with complement components established essential roles for IgG and the components of the classical complement pathway through C3 for neutralization. The components of the alternative and membrane attack pathways were not needed for neutralization. As anticipated from the requirement for IgG and exclusive mediation of neutralization by the classical pathway, the virus-IgG immune complex activated purified C1. Binding of C3 and C4 to the virus was demonstrated, as was classical pathway-mediated triggering of the alternative pathway, with recruitment of properdin. In addition, the H1N1 influenza virus also directly activated the alternative complement pathway in human serum, leading to C3 and properdin deposition on the viral envelope. Such direct alternative pathway activation also required immunoglobulin. However, the alternative pathway alone was unable to neutralize the virus. Thus, most normal sera examined contain low levels of IgG anti-hemagglutinin antibody, which activate the classical pathway of the complement system and neutralize WS/33 influenza virus by deposition of C3 and C4 on the viral envelope.     

Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting

Sera from 28 patients with bullous pemphigoid (BP), four patients with cicatricial pemphigoid (CP), and 24 controls (normal volunteers and patients with pemphigus, systemic lupus erythematosus, or other skin diseases) were tested against extracts of human epidermis by immunoblotting techniques. The extraction buffer included 1% SDS, 5% beta-mercaptoethanol, and six protease inhibitors with various specificities. BP sera from individual patients showed different patterns of reactivity with the same epidermal extract, and each pattern consisted of one or more bands. A total of five bands of 240 kD, 200 kD, 180 kD, 97 kD, and 77 kD reacted with BP sera; the 240-kD band reacted with one CP sera, and none of these bands was detected by the control sera. The 240-kD and 180-kD bands reacted very strongly with some sera and were most frequently observed (43% and 29%, respectively). The 200-kD, 97-kD, and 77-kD bands were less frequently observed (25%, 7%, and 7%, respectively), but when present, their reactions were usually strong. Eleven percent of the BP sera did not react with any bands. Contrary to previous reports, this study shows that BP autoantibodies react with several protein bands, as detected by immunoblotting. We have recently shown by immunoelectron microscopy that BP autoantibodies bind to the basal cell hemidesmosomes. It remains to be determined which of these protein bands represent specific hemidesmosomal proteins and which antibody-antigen interactions are relevant to the pathogenesis of this disease.     

Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein

We previously reported a number of features of hepatitis C virus (HCV) chimeric glycoproteins related to pseudotype virus entry into mammalian cells. In this study, pseudotype virus was neutralized by HCV E2 glycoprotein-specific antibodies and infected human sera. Neutralization (50% reduction of pseudotype virus plaque formation) was observed with two human immunoglobulin G1 monoclonal antibodies (MAbs) at concentrations of between 2.5 and 10 microg/ml. A hyperimmune rabbit antiserum to an E2 hypervariable region 1 (HVR1) mimotope also exhibited an HCV E2 pseudotype virus neutralization titer of approximately 1/50. An E1 pseudotype virus used as a negative control was not neutralized to a significant level (<1/10) by these MAbs or rabbit antiserum to E2 HVR1. Since HCV probably has a lipid envelope, the role of complement in antibody-mediated virus neutralization was examined. Significant increases in the neutralization titers of the human MAbs (approximately 60- to 160-fold higher) and rabbit antiserum to HVR1 mimotopes (approximately 10-fold higher) were observed upon addition of guinea pig complement. Further, these studies suggested that complement activation occurred primarily by the classical pathway, since a deficiency in the C4 component led to a significant decrease in the level of virus neutralization. This same decrease was not observed with factor B-deficient complement. We also determined that 9 of 56 HCV-infected patient sera (16%) had detectable pseudotype virus neutralization activity at serum dilutions of between 1/20 and 1/50 and that complement addition enhanced the neutralization activity of some of the HCV-infected human sera. Taken together, these results suggest that during infection, HCV E2 glycoprotein induces a weak neutralizing antibody response, that those antibodies can be measured in vitro by the surrogate pseudotype virus plaque reduction assay, and that neutralization function can be augmented by complement.     

Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody

Glycoprotein C (gC) of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) binds complement component C3b and protects virus from complement-mediated neutralization. Differences in complement interacting domains exist between gC of HSV-1 (gC1) and HSV-2 (gC2), since the amino terminus of gC1 blocks complement C5 from binding to C3b, while gC2 fails to interfere with this activity. We previously reported that neutralization of HSV-1 gC-null virus by HSV antibody-negative human serum requires activation of C5 but not of downstream components of the classical complement pathway. In this report, we evaluated whether activation of C5 is sufficient to neutralize HSV-2 gC-null virus, or whether formation of the membrane attack complex by C6 to C9 is required for neutralization. We found that activation of the classical complement pathway up to C5 was sufficient to neutralize HSV-2 gC-null virus by HSV antibody-negative human serum. We evaluated the mechanisms by which complement activation occurred in seronegative human serum. Interestingly, natural immunoglobulin M antibodies bound to virus, which triggered activation of C1q and the classical complement pathway. HSV antibody-negative sera obtained from four individuals differed over an approximately 10-fold range in their potency for complement-mediated virus neutralization. These findings indicate that humans differ in the ability of their innate immune systems to neutralize HSV-1 or HSV-2 gC-null virus and that a critical function of gC1 and gC2 is to prevent C5 activation.